Shopping Cart
- Remove All
Your shopping cart is currently empty
(8)
By Tag- C-His-Avi
- C-His(3)
- N-6xHis(2)
- N-6xHis-SUMO(2)
- N-GST(2)
- C-6xHis(1)
- C-mFc(1)
- N-10xHis(1)
- N-His(1)
- Tag Free(1)
Filter
Applied FilterClear all
By Tag By Expression System- HEK293 Cells(12)
- E. coli(8)
- Baculovirus Insect Cells(1)
By Species- Human(11)
- Human & Mouse(2)
- Rat(2)
- Amaranthus caudatus(1)
- Cynomolgus(1)
- EBV(1)
- Horse(1)
- Mouse(1)
- Myrmecia pilosula(1)
By SPR-compatible Buffer- Ready-to-use(14)
- Buffer-exchangeable(7)
Filter
Search Result
Results for "
MP2
" in TargetMol Product Catalog- Inhibitors & Agonists16
- Peptide Products2
- Inhibitory Antibodies1
- Recombinant Protein21
- Antibody Products16
Compareperipheral myelin protein 2, P2, MP2, M-FABP, FABP8
TMPY-01563
Expression system: E. coli
Length: 2-132, Full Length of Mature Protein
Activity: Not Tested
Length: 2-132, Full Length of Mature Protein
Activity: Not Tested
- Inquiry Price
Size
QTY
SPR-compatible buffer
CompareTerminal protein, LMP2, Latent membrane protein 2
TMPH-00544
Expression system: E. coli
Length: 1-147, Partial
Activity: Not Tested
Length: 1-147, Partial
Activity: Not Tested
- Inquiry Price
Size
QTY
Buffer-exchangeable
ComparePMP2, Myelin P2 protein
TMPH-00831
Expression system: E. coli
Length: 2-132, Full Length of Mature Protein
Activity: Not Tested
Length: 2-132, Full Length of Mature Protein
Activity: Not Tested
- Inquiry Price
Size
QTY
Buffer-exchangeable
CompareProtein JTV-1, Multisynthase complex auxiliary component p38, JTV1, Aminoacyl tRNA synthase complex-interacting multifunctional protein 2, AIMP2
TMPH-00927
Expression system: E. coli
Length: 1-320, Full Length
Activity: Not Tested
Length: 1-320, Full Length
Activity: Not Tested
- Inquiry Price
Size
QTY
Buffer-exchangeable
ComparePilosin-3 subunit b (Pilosulin-3b), M-myrmeciitoxin-Mp2b, M-MIITX-Mp2b, DELTA-myrtoxin-Mp1a B chain (Mp1a B chain)
TMPH-03035
Expression system: Baculovirus Insect Cells
Length: 1-23, Full Length
Activity: Not Tested
Length: 1-23, Full Length
Activity: Not Tested
- Inquiry Price
Size
QTY
Buffer-exchangeable
CompareSR13 myelin protein, Schwann cell membrane glycoprotein (SAG), Protein CD25, PMP-22, Pmp-22, Pmp22, Peripheral myelin protein 22, Cd25
TMPH-03350
Expression system: E. coli
Length: 1-160, Full Length
Activity: Not Tested
Length: 1-160, Full Length
Activity: Not Tested
- Inquiry Price
Size
QTY
Buffer-exchangeable
CompareVesicle-associated membrane protein 2, VAMP-2, Vamp2, Synaptobrevin-2, Syb2
TMPH-03399
Expression system: E. coli
Length: 2-94, Partial
Activity: Not Tested
Length: 2-94, Partial
Activity: Not Tested
- Inquiry Price
Size
QTY
Buffer-exchangeable
CompareVacuolar protein sorting-associated protein 2-2 (Vps2-2;hVps2-2), Chromatin-modifying protein 2b (CHMP2b), CHMP2B, CHMP2.5, Charged multivesicular body protein 2b
TMPH-03864
Expression system: E. coli
Length: 2-213, Full Length of Mature Protein
Activity: Not Tested
Length: 2-213, Full Length of Mature Protein
Activity: Not Tested
- Inquiry Price
Size
QTY
Buffer-exchangeable
CompareAntimicrobial peptide 2, AMP2
TMPH-04792
AMP2 Protein, Amaranthus caudatus, Recombinant (GST) is expressed in E. coli. The accession number is P27275.
- Inquiry Price
Size
QTY
SPR-compatible buffer
CompareRMF, RING12, PSMB9, Proteasome chain 7, MHC, Macropain chain 7, LMP-2, LMP2
TMPK-01498
The immunoproteasome, having been linked to neurodegenerative diseases and hematological cancers, has been shown to play an important role in MHC class I antigen presentation. The development of molecular probes that selectively inhibit the major catalytic subunit, LMP2, of the immunoproteasome,LMP2-rich cancer cells compared to LMP2-deficient cancer cells are more sensitive to growth inhibition by the LMP2-specific inhibitor, implicating an important role of LMP2 in regulating cell growth of malignant tumors that highly express LMP2.
- Inquiry Price
Size
QTY
SPR-compatible buffer
CompareRMF, RING12, PSMB9, Proteasome chain 7, MHC, Macropain chain 7, LMP-2, LMP2
TMPK-01502
The immunoproteasome, having been linked to neurodegenerative diseases and hematological cancers, has been shown to play an important role in MHC class I antigen presentation. The development of molecular probes that selectively inhibit the major catalytic subunit, LMP2, of the immunoproteasome,LMP2-rich cancer cells compared to LMP2-deficient cancer cells are more sensitive to growth inhibition by the LMP2-specific inhibitor, implicating an important role of LMP2 in regulating cell growth of malignant tumors that highly express LMP2.
- Inquiry Price
Size
QTY
SPR-compatible buffer
CompareRMF, RING12, PSMB9, Proteasome chain 7, MHC, Macropain chain 7, LMP-2, LMP2
TMPK-01503
The immunoproteasome, having been linked to neurodegenerative diseases and hematological cancers, has been shown to play an important role in MHC class I antigen presentation. The development of molecular probes that selectively inhibit the major catalytic subunit, LMP2, of the immunoproteasome,LMP2-rich cancer cells compared to LMP2-deficient cancer cells are more sensitive to growth inhibition by the LMP2-specific inhibitor, implicating an important role of LMP2 in regulating cell growth of malignant tumors that highly express LMP2.
- Inquiry Price
Size
QTY
SPR-compatible buffer
CompareRMF, RING12, PSMB9, Proteasome chain 7, MHC, Macropain chain 7, LMP-2, LMP2
TMPK-01530
The immunoproteasome, having been linked to neurodegenerative diseases and hematological cancers, has been shown to play an important role in MHC class I antigen presentation. The development of molecular probes that selectively inhibit the major catalytic subunit, LMP2, of the immunoproteasome,LMP2-rich cancer cells compared to LMP2-deficient cancer cells are more sensitive to growth inhibition by the LMP2-specific inhibitor, implicating an important role of LMP2 in regulating cell growth of malignant tumors that highly express LMP2.
- Inquiry Price
Size
QTY
SPR-compatible buffer
CompareRMF, RING12, PSMB9, Proteasome chain 7, MHC, Macropain chain 7, LMP-2, LMP2
TMPK-01533
The immunoproteasome, having been linked to neurodegenerative diseases and hematological cancers, has been shown to play an important role in MHC class I antigen presentation. The development of molecular probes that selectively inhibit the major catalytic subunit, LMP2, of the immunoproteasome,LMP2-rich cancer cells compared to LMP2-deficient cancer cells are more sensitive to growth inhibition by the LMP2-specific inhibitor, implicating an important role of LMP2 in regulating cell growth of malignant tumors that highly express LMP2.
- Inquiry Price
Size
QTY
SPR-compatible buffer
CompareRMF, RING12, PSMB9, Proteasome chain 7, MHC, Macropain chain 7, LMP-2, LMP2
TMPK-01534
The immunoproteasome, having been linked to neurodegenerative diseases and hematological cancers, has been shown to play an important role in MHC class I antigen presentation. The development of molecular probes that selectively inhibit the major catalytic subunit, LMP2, of the immunoproteasome,LMP2-rich cancer cells compared to LMP2-deficient cancer cells are more sensitive to growth inhibition by the LMP2-specific inhibitor, implicating an important role of LMP2 in regulating cell growth of malignant tumors that highly express LMP2.
- Inquiry Price
Size
QTY
SPR-compatible buffer
CompareRMF, RING12, PSMB9, Proteasome chain 7, MHC, Macropain chain 7, LMP-2, LMP2
TMPK-01535
The immunoproteasome, having been linked to neurodegenerative diseases and hematological cancers, has been shown to play an important role in MHC class I antigen presentation. The development of molecular probes that selectively inhibit the major catalytic subunit, LMP2, of the immunoproteasome,LMP2-rich cancer cells compared to LMP2-deficient cancer cells are more sensitive to growth inhibition by the LMP2-specific inhibitor, implicating an important role of LMP2 in regulating cell growth of malignant tumors that highly express LMP2.
- Inquiry Price
Size
QTY
SPR-compatible buffer
CompareRMF, RING12, PSMB9, Proteasome chain 7, MHC, Macropain chain 7, LMP-2, LMP2
TMPK-01542
The immunoproteasome, having been linked to neurodegenerative diseases and hematological cancers, has been shown to play an important role in MHC class I antigen presentation. The development of molecular probes that selectively inhibit the major catalytic subunit, LMP2, of the immunoproteasome,LMP2-rich cancer cells compared to LMP2-deficient cancer cells are more sensitive to growth inhibition by the LMP2-specific inhibitor, implicating an important role of LMP2 in regulating cell growth of malignant tumors that highly express LMP2.
- Inquiry Price
Size
QTY
SPR-compatible buffer
Comparetransmembrane emp24-like trafficking protein 10 (yeast), Tmp-21-I, TMP21, S31III125, S31I125, P24(δ), P24(DELTA), p23
TMPY-00499
Expression system: HEK293 Cells
Length: 1-185, Partial
Activity: Not Tested
Length: 1-185, Partial
Activity: Not Tested
- Inquiry Price
Size
QTY
SPR-compatible buffer
CompareMac3, lysosomal-associated membrane protein 2, LGP-B, LampII, Lamp-2c, Lamp-2b, Lamp-2a, Lamp-2, CD107b
TMPY-02382
Expression system: HEK293 Cells
Length: 26-379, Partial
Activity: Not Tested
Length: 26-379, Partial
Activity: Not Tested
- Inquiry Price
Size
QTY
SPR-compatible buffer
Comparelysosomal-associated membrane protein 2
TMPY-03685
LAMP2 Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 42.4 kDa and the accession number is G7Q3L7.
- Inquiry Price
Size
QTY
SPR-compatible buffer
Comparelysosomal-associated membrane protein 2, LGP110, LAMPB, LAMP-2, CD107b
TMPY-04115
Expression system: HEK293 Cells
Length: 1-375, Partial
Activity: Not Tested
Length: 1-375, Partial
Activity: Not Tested
- Inquiry Price
Size
QTY
SPR-compatible buffer
Go to page 1
Page of 1
Product Comparison
| Product |
|---|
| Bioactive |
| Species |
| Expression System |
| Tag |
| Accession Number |
| Amino Acid |
| Construction |
| Molecular Weight |
| Endotoxin |
| Formulation |
| Reconstitution |
| Stability & Storage |
| Shipping |
| Research Background |
| Size |
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.